2016-03-11T00:00:00.000-05:00
current price,0.456929
price objective,0.240534
price target,0.456929
Asset Management LLC,0.349526
Balyasny Asset Management,0.253505
Adams Street Partners,0.278225
stock,0.094878
Zacks Investment Research‘s,0.456929
InvestorPlace Broker Center,0.555736
vice president,0.214786
biopharmaceutical company,0.410278
personal trading style,0.598412
Zacks Investment Research,0.319993
Visium Asset Management,0.324471
average rating,-0.247964
oncomed pharmaceuticals,0.364741
Pharmaceuticals Inc Daily,0.397938
average price,0.238539
consensus estimate,0.321141
shares,0.105264
company’s stock,0.617672
executive vice president,0.214786
concise daily summary,0.505807
development-stage biopharmaceutical company,0.385476
consensus target price,0.440905
MarketBeat reports,-0.286175
stock broker,0.245696
Street Partners LLC,0.278225
cancer therapy patients,-0.605697
rating,0.0629995
Eventide Asset Management,0.445547
quarterly earnings data,-0.27715
Asset Management LP,0.324471
equities research analyst,0.417149
new stake,0.253505
quarter,-0.0179783
